Disclosure 0001193125-26-427545-1

SEC FORM 4

—

HERON THERAPEUTICS, INC. /DE/ (HRTX)

Acquisition (code M) of 3,874 shares; price not stated (see filing).

Reporting Person Duarte Ira · Officer Title EVP, Chief Financial Officer · Transaction Code M

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001193125-26-427545 · filed 2026-10-21 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "HERON THERAPEUTICS, INC. /DE/ (HRTX)." Disclosed 2026-10-21. https://desqlong.com/cards/0001193125-26-427545-1 (retrieved 2026-10-22).